NCT02563067 Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. Status COMPLETED Phase PHASE3
NCT02559622 Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab Status COMPLETED Phase PHASE3
NCT02555683 Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. Status COMPLETED Phase PHASE3
NCT02554890 Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. Status COMPLETED Phase PHASE4
NCT02554786 A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma Status COMPLETED Phase PHASE3
NCT02551224 Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase NA
NCT02550106 Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment Status COMPLETED Phase PHASE4
NCT02547714 Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A Status COMPLETED Phase PHASE4
NCT02546674 Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline. Status COMPLETED Phase PHASE4
NCT02543086 Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos Status TERMINATED Phase PHASE1
NCT02539459 Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Status TERMINATED Phase PHASE2
NCT02537223 Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT02534909 Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria Status COMPLETED Phase PHASE2
NCT02524119 LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT02520752 A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02520063 Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02518750 Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma Status TERMINATED Phase PHASE2
NCT02516605 A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients Status COMPLETED Phase PHASE2
NCT02516592 Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort Status COMPLETED Phase PHASE4